Picture of Akeso logo

9926 Akeso Income Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapMomentum Trap

Annual income statement for Akeso, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue2268384,5262,1243,056
Cost of Revenue
Gross Profit1957354,3891,8232,404
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1,4732,2172,4972,5574,066
Operating Profit-1,248-1,3792,030-433-1,010
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-1,258-1,4221,943-501-1,141
Provision for Income Taxes
Net Income After Taxes-1,258-1,4221,942-501-1,141
Minority Interest
Net Income Before Extraordinary Items
Net Income-1,075-1,1682,028-515-1,113
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-1,075-1,1682,028-515-1,113
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-1.32-1.422.42-0.605-1.23